KORU Medical Systems, Inc.
NASDAQKRMD just reported Q1 2026 results that came in ahead of expectations. Revenue hit $11.77 million, beating the $11.28 million estimate. Management held full-year guidance at $47.5–$50.0 million, in line with the consensus estimate of $48.5 million. The stock entered the print in a constructive posture. Price closed at $4.08 on May 5, flat on the week but down about 6% over the past…
Snapshot as of 7 May 2026
KRMD just reported Q1 2026 results that came in ahead of expectations. Revenue hit $11.77 million, beating the $11.28 million estimate. Management held full-year guidance at $47.5–$50.0 million, in line with the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for KRMD — free to start on ORTEX.
Sign up for free →Open KRMD on ORTEX